A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Clinical trial NCT01609933 · COMPLETED
Trial details
- NCT number
- NCT01609933
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-18
- Primary completion
- 2017-05-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.